Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.340
+0.140 (3.33%)
At close: Jun 23, 2026, 4:00 PM EDT
4.627
+0.287 (6.61%)
After-hours: Jun 23, 2026, 7:28 PM EDT

Camp4 Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Camp4 Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.58. The average 1-year stock price forecast is 97.70% higher than the current stock price, while the lowest is $6.50 (+49.77%) and the highest is $12 (+176.50%).

Price Target: $8.58 (+97.70%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$6.50$8.58$8.50$12
Change+49.77%+97.70%+95.85%+176.50%

Analyst Ratings

The average analyst rating for Camp4 Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy444445
Buy111112
Hold111110
Sell000000
Strong Sell000000
Total666667

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Upgrades
$5$9
BuyUpgrades$5$9+107.37%Jun 16, 2026
Chardan Capital
Chardan Capital
Buy
Initiates
$6.5
BuyInitiates$6.5+49.77%Jun 10, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$12
BuyReiterates$12+176.50%May 15, 2026
Wedbush
Wedbush
Buy
Maintains
$8
BuyMaintains$8+84.33%May 8, 2026
William Blair
William Blair
Buy
Reiterates
n/a
BuyReiteratesn/an/aMay 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
6.27M
from 3.50M
Increased by 79.11%
Revenue Next Year
6.82M
from 6.27M
Increased by 8.79%
EPS This Year
-0.79
from -1.65
EPS Next Year
-0.78
from -0.79
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-350.00K652.00K3.50M6.27M
Revenue Growth
--86.29%436.50%79.11%
Operating Income
-45.00M-51.88M-53.09M-52.06M-57.19M
Net Income
-44.19M-49.29M-51.79M-80.40M-56.12M
EPS
----1.65-0.79
Free Cash Flow
--30.18M-26.52M-20.64M-51.00M
No. Analysts
----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High9.6M
Avg6.3M
Low1.3M

Revenue Growth

Revenue Growth202620272028
High
174.4%
Avg
79.1%
Low
-63.0%

EPS Forecast

EPS202620272028
High-0.68
Avg-0.79
Low-0.97

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-